Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/30/2008CA2688670A1 Src family kinase inhibitors
10/30/2008CA2685278A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/30/2008CA2685153A1 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
10/30/2008CA2685141A1 New compounds 806
10/30/2008CA2685127A1 Glycoconjugates of rna interference agents
10/30/2008CA2684965A1 Phthalazine and isoquinoline derivatives with s1p receptor modulating activities
10/30/2008CA2684950A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
10/30/2008CA2684949A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
10/30/2008CA2684866A1 Therapeutic agent for glaucoma containing adenosine derivative as active ingredient
10/30/2008CA2684841A1 Beverage composition comprising cla
10/30/2008CA2684837A1 Desferrithiocin analogue actinide decorporation agents
10/30/2008CA2684835A1 Dermatological composition for the prevention and/or treatment of rosacea, of couperose or of skin which exhibits diffuse redness or small dilated vessels
10/30/2008CA2684760A1 Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives
10/30/2008CA2684741A1 Low calcemic, highly antiproliferative, analogs of calcitriol
10/30/2008CA2684718A1 A foam material for medical use and method for producing same
10/30/2008CA2684701A1 Pyrazoles useful in the treatment of inflammation
10/30/2008CA2684659A1 Tricyclic nitrogen containing compounds as antibacterial agents
10/30/2008CA2684644A1 Quinoline-carboxamide derivatives as p2y12 antagonists
10/30/2008CA2684638A1 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof
10/30/2008CA2684634A1 Pyrimidinone derivatives and methods of use thereof
10/30/2008CA2684633A1 Pyrimidinone derivatives and methods of use thereof
10/30/2008CA2684618A1 Tetrahydropyrido[4,3-d]pyrimidinone derivatives and methods of use thereof
10/30/2008CA2684615A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/30/2008CA2684599A1 Crystalline forms of topotecan hydrochloride and processes for making the same
10/30/2008CA2684594A1 Benzimidazoles and pharmaceutical compositions thereof
10/30/2008CA2684591A1 Subsituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
10/30/2008CA2684586A1 High dose composition of ursodeoxycholic acid
10/30/2008CA2684552A1 Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds
10/30/2008CA2684550A1 Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
10/30/2008CA2684480A1 Lipoic acid derivatives
10/30/2008CA2684479A1 Pharmaceutical formulations containing lipoic acid derivatives
10/30/2008CA2684450A1 Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding
10/30/2008CA2684385A1 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
10/30/2008CA2684360A1 Use of fungicides for the treatment of fish mycoses
10/30/2008CA2684356A1 Oxazolidinones for the treatment and prophylaxis of pulmonary hypertension
10/30/2008CA2684347A1 A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701
10/30/2008CA2684342A1 Use of fungicides for the treatment of fish mycoses
10/30/2008CA2684278A1 Method for inhibiting scavenger receptor-a and increasing immune response to antigens
10/30/2008CA2684240A1 Tetrahydroindole and tetrahydroindazole derivatives
10/30/2008CA2684170A1 Process for dosing self-emulsifying drug delivery systems
10/30/2008CA2684084A1 Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
10/30/2008CA2684003A1 Novel compounds as cannabinoid receptor ligands
10/30/2008CA2683958A1 Topical fungicidal agents for treating nail disorders
10/30/2008CA2683948A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/30/2008CA2683946A1 Triazole derivatives which are smo antagonists
10/30/2008CA2683809A1 Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogen
10/30/2008CA2683786A1 Titration of tapentadol
10/30/2008CA2683779A1 Tapentadol for treating pain due to osteoarthritis
10/30/2008CA2683758A1 Novel 1,8-naphthyridine compounds
10/30/2008CA2683757A1 Aryl heterocyclic cgrp receptor antagonists
10/30/2008CA2683745A1 Bicyclic anilide heterocyclic cgrp receptor antagonists
10/30/2008CA2683672A1 Ophthalmic oil-in-water emulsions containing prostaglandins
10/30/2008CA2683534A1 Novel pyrimidine compound having dibenzylamine structure and medicament comprising the same
10/30/2008CA2683517A1 Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases
10/30/2008CA2683111A1 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
10/30/2008CA2683083A1 Methods of diagnosing alzheimer's disease and markers identified by set association
10/30/2008CA2683053A1 Oligonucleotide compositions for the treatment of alzheimer's disease
10/30/2008CA2682994A1 Heterocyclic compounds with affinity to muscarinic receptors
10/30/2008CA2682692A1 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
10/30/2008CA2682671A1 Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
10/30/2008CA2682668A1 Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
10/30/2008CA2682539A1 Compounds comprising a cyclobutoxy group
10/30/2008CA2682506A1 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
10/30/2008CA2682356A1 7-substituted indole mcl-1 inhibitors
10/30/2008CA2682354A1 7-nonsubstituted indole mcl-1 inhibitors
10/30/2008CA2682301A1 Xanthine compounds having a positive allosteric gabab receptor modulator effect
10/30/2008CA2681850A1 Styrenyl derivative compounds for treating ophthalmic diseases and disorders
10/30/2008CA2681181A1 Sustained release
10/30/2008CA2680769A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
10/30/2008CA2680039A1 Pharmaceutical composition comprising edoxaban, an anticoagulant
10/30/2008CA2678801A1 Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers
10/30/2008CA2678639A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
10/30/2008CA2678007A1 Pyrrolo[2,3-b]pyridine compounds, azaindole compounds used for synthesizing said pyrrolo[2,3-b]pyridine compounds, methods for the production thereof, and uses thereof
10/30/2008CA2659603A1 Oil producing microbes and methods of modification thereof
10/30/2008CA2656157A1 Transcription factor modulating compounds and methods of use thereof
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
10/29/2008EP1985702A2 CPG-like nucleic acids and methods of use thereof
10/29/2008EP1985701A2 Genes differentially expressed in breast cancer
10/29/2008EP1985620A1 10a-AZALIDE COMPOUND
10/29/2008EP1985612A1 Arymethylen substituted N-Acyl-gamma-aminoalcohols
10/29/2008EP1985310A1 Solid dosage forms
10/29/2008EP1985309A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance
10/29/2008EP1985308A2 Water-soluble compositions of bioactive lipophilic compounds
10/29/2008EP1985307A2 Method and preparation for preventing and/or treating depression
10/29/2008EP1985299A1 Therapeutic agent for traumatic neuropathy and/or movement disorder
10/29/2008EP1985298A1 Ophtalmic oil-in-water emulsions containing prostaglandins
10/29/2008EP1985297A1 Carboxylic acid compound and use thereof
10/29/2008EP1985296A1 New substituted pentabasic azaheterocyclic compounds and its use of treating protein aging disease
10/29/2008EP1985295A1 Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
10/29/2008EP1985294A1 Agent for improvement of hepatic function
10/29/2008EP1985293A1 Method for producing denatured substance of lactalbumin
10/29/2008EP1985292A1 Titration of tapentadol
10/29/2008EP1985291A2 Endodontic fibers and methods of use therefor
10/29/2008EP1985286A1 Microspheres for treatment of brain tumours
10/29/2008EP1985285A2 Compositions and methods for treating lymphoma
10/29/2008EP1985283A1 Gel-forming composition for medical use, devices for the application of the composition, and drug release controlling carrier
10/29/2008EP1985191A1 Preparation of polyfunctional fermented food products
10/29/2008EP1984734A2 Sigma-2 receptor, method of screening of specific ligands and use of the same in diagnostic or therapeutic methods
10/29/2008EP1984546A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects
1 ... 3021 3022 3023 3024 3025 3026 3027 3028 3029 3030 3031 3032 3033 3034 3035 3036 3037 3038 3039 3040 3041 ... 7860